Avego Management, a healthcare investment firm, led a $40m Series A funding round in AtomVie Global Radiopharma, a manufacturer and supplier of finished-dose therapeutic radiopharmaceuticals. "Avego is thrilled to partner with AtomVie to support the continued growth of one of the leading radiopharmaceutical CDMOs. The AtomVie team and their collective radiopharmaceutical expertise are second to none, and our partnership will advance the development of radiopharmaceuticals and improve patient outcomes," Thomas Vandervort, Avego Managing Partner.